Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-23-028417
Filing Date
2023-06-05
Accepted
2023-06-05 17:16:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFM14A ny20009214x2_defm14a.htm DEFM14A 580028
2 ny20009214x2_pc1.jpg GRAPHIC 575727
3 ny20009214x2_pc2.jpg GRAPHIC 413026
  Complete submission text file 0001140361-23-028417.txt   1942055
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36644 | Film No.: 23993801
SIC: 2834 Pharmaceutical Preparations